Delivery Order SPE2DB22D3016-SPE2DB24FBBR7

Award Date 7/22/24
Potential Completion Date 7/23/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award provides for the delivery of OxyContin ER 10 mg tablets to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, in the amount of $1,503.13. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
This federal contract award is for the delivery of Oxycontin ER 15 mg tablets in 100-count bottles. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for a ceiling value of $2,568.92. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award is for the delivery of OxyContin ER 20 mg tablets in 100-count packages to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract has a ceiling value of $2,005.52 and an ultimate completion date of May 9, 2024. It was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as a delivery order under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support...
This federal contract award is for the delivery of Oxycontin ER 15 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The ceiling value of the contract is $1,132.74, with a period of performance through July 10, 2023. The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a delivery order under a larger Indefinite Delivery...
This federal contract award is for the delivery of OxyContin ER 20 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $1,844.15 firm fixed price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 28, 2022, with a performance period ending on July 29, 2022. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and has an Indefinite Delivery...
This federal contract award is for the delivery of Oxycontin ER 15 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 14, 2022, with a ceiling value of $1,317.63 and a completion date of December 15, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This...
This federal contract award is for the delivery of OxyContin ER 10 mg tablets, with a ceiling value of $9,462.69 and an ultimate completion date of April 23, 2024. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen, a major pharmaceutical distribution company, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025....
The federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OxyContin ER 20 mg tablets. The contract, valued at $2,657.37, is a delivery order with a firm-fixed price type and an ultimate completion date of September 10, 2024. This award is not associated with a set-aside program. AmerisourceBergen, through its Corporate Office division, will supply the medication to support military treatment...
This federal contract award is for the delivery of Oxycontin ER 10 mg tablets in quantities of 100 per bottle. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,497.87 and is a firm fixed price delivery order with an ultimate completion date of October 31, 2024. This award is not designated with a set-aside requirement. Amerisourcebergen holds...
This federal contract award is for the delivery of Oxycontin ER 10mg tablets to the Defense Logistics Agency (DLA). The $1,060.38 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on September 16, 2024. The contract has an ultimate completion date of September 17, 2024 and is not associated with any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBBR7
    Delivery Order

The federal contract award is for the delivery of OxyContin ER 10 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,204.17, was awarded to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor in the United States. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is scheduled for completion on July 23, 2024.

Generated 10/21/24, 9:41 AM